calculated based trials unvaccinated placebo control group end trial look number control group ended symptomatic covid baseline infection rate pfizer biontech vaccine instance 95 percent efficacy clinical trial number came fact 162 people placebo group got symptomatic covid people vaccinated group approximately percent 170 essentially efficacy calculated covid vaccine clinical trials reported efficacy preventing symptomatic disease not necessarily severe disease early data promising yes seen current vaccines severe symptoms hospitalizations deaths vaccinated people infected vaccine trials observed reduction severe disease vaccinated subjects exceptions possibly astrazeneca vaccine south africa vaccines appear reduce risk getting symptomatic covid likely severe case data far